WinHealth International. As at 30 June 2020, the Group held approximately 8.11% equity interest in WinHealth International with an investment amount of approximately RMB47.25 million (equivalent to approximately HK$53.4 million) and a fair value of approximately RMB67.9 million (equivalent to approximately HK$74.
